Expertise in
22
conditions

Dr. Mokenge P. Malafa

General Surgery
Moffitt Cancer Center, Magnolia Campus
12902 Usf Magnolia Dr, 
Tampa, FL 
Accepting New Patients
Offers Telehealth
Expertise in
22
conditions
Moffitt Cancer Center, Magnolia Campus
12902 Usf Magnolia Dr, 
Tampa, FL 

Overview

Mokenge Malafa is a General Surgeon practicing medicine in Tampa, Florida.

Dr. Malafa is highly rated in 22 conditions, according to our data. His clinical expertise encompasses Pancreatic Cancer, Familial Pancreatic Cancer, Pancreatic Ductal Adenocarcinoma, Pancreatectomy, and Small Bowel Resection.

He is actively involved in clinical research, co-authoring 152 peer reviewed articles and participating in 5 clinical trials. Dr. Malafa is currently accepting new patients.

Specialties

General Surgery

Licenses

Surgery in FL

Languages Spoken

English
French

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Florida Blue
  • EPO
  • PPO
Health Options
  • HMO
  • POS
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Quartz Health Plan
  • HMO
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • OTHER COMMERCIAL
  • OTHER MEDICARE PART D
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 6 Less Insurance Carriers -

Locations

Moffitt Cancer Center, Magnolia Campus
12902 Usf Magnolia Dr, Tampa, FL 33612

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

5 Clinical Trials

The Florida Pancreas Collaborative Next-Generation Biobank: Reducing Health Disparities and Improving Survival for Pancreatic Cancer
The Florida Pancreas Collaborative Next-Generation Biobank: Reducing Health Disparities and Improving Survival for Pancreatic Cancer
Enrollment Status: Active_not_recruiting
Publish Date: June 26, 2026
Intervention Type: Other
Randomized Trial of Prolonged Use of Negative Pressure Wound Therapy in Patients Undergoing Surgical Procedures for the Management of Gastrointestinal Malignancies
Randomized Trial of Prolonged Use of Negative Pressure Wound Therapy in Patients Undergoing Surgical Procedures for the Management of Gastrointestinal Malignancies
Enrollment Status: Completed
Publish Date: June 09, 2026
Intervention Type: Device
Study Phase: Phase 2/Phase 3
A Double Blind Placebo-Controlled Trial of Eflornithine and Sulindac to Prevent Recurrence of High Risk Adenomas and Second Primary Colorectal Cancers in Patients With Stage 0-III Colon or Rectal Cancer, Phase III - Preventing Adenomas of the Colon With Eflornithine and Sulindac (PACES)
A Double Blind Placebo-Controlled Trial of Eflornithine and Sulindac to Prevent Recurrence of High Risk Adenomas and Second Primary Colorectal Cancers in Patients With Stage 0-III Colon or Rectal Cancer, Phase III - Preventing Adenomas of the Colon With Eflornithine and Sulindac (PACES)
Enrollment Status: Active_not_recruiting
Publish Date: April 02, 2026
Intervention Type: Drug
Study Phase: Phase 3
Preoperative Extended Chemotherapy vs. Chemotherapy Plus Hypofractionated Radiation Therapy for Borderline Resectable Adenocarcinoma of the Head of the Pancreas
Preoperative Extended Chemotherapy vs. Chemotherapy Plus Hypofractionated Radiation Therapy for Borderline Resectable Adenocarcinoma of the Head of the Pancreas
Enrollment Status: Unknown
Publish Date: May 24, 2022
Intervention Type: Drug, Procedure, Radiation
Study Drugs: mFOLFIRINOX, FOLFOX
Study Phase: Phase 2
Total Tumor Mapping (TTM) for Resectable Pancreatic Cancer: Establishing the Radiomic/Pathologic Foundation of Heterogeneity
Total Tumor Mapping (TTM) for Resectable Pancreatic Cancer: Establishing the Radiomic/Pathologic Foundation of Heterogeneity
Enrollment Status: Withdrawn
Publish Date: February 08, 2021
Intervention Type: Procedure, Drug
Study Phase: Early Phase 1
View 4 Less Clinical Trials

152 Total Publications

Implementing Timely Germline Genetic Testing for Patients With Pancreatic Cancer Using a Genetics Copilot for Point-of-Care Education and Health Assessment.
Implementing Timely Germline Genetic Testing for Patients With Pancreatic Cancer Using a Genetics Copilot for Point-of-Care Education and Health Assessment.
Journal: JCO precision oncology
Published: June 29, 2026
Similar Doctors
Expertise in
30
conditions
Dr. Sharona B. Ross
General Surgery
Expertise in
30
conditions
Dr. Sharona B. Ross
General Surgery
Referral may be required

AdventHealth Medical Group General Surgery At Tampa

3000 Medical Park Dr Ste 500, 
Tampa, FL 
 (2.4 miles away)
941-363-6717
Languages Spoken:
English, Hebrew
See accepted insurances
Accepting New Patients
Offers Telehealth

Sharona Ross is a General Surgeon practicing medicine in Tampa, Florida. Dr. Ross is highly rated in 30 conditions, according to our data. Her clinical expertise encompasses Hiatal Hernia, Gastroesophageal Reflux Disease (GERD), Hernia, Pancreaticoduodenectomy, and Gallbladder Removal. Dr. Ross is currently accepting new patients.

Expertise in
30
conditions
Dr. Iswanto L. Sucandy
General Surgery
Expertise in
30
conditions
Dr. Iswanto L. Sucandy
General Surgery
Referral may be required

AdventHealth Medical Group General Surgery At Tampa

3000 Medical Park Dr Ste 500, 
Tampa, FL 
 (2.4 miles away)
813-615-7030
Languages Spoken:
English, Bahasa
See accepted insurances
Accepting New Patients
Offers Telehealth

Iswanto Sucandy is a General Surgeon practicing medicine in Tampa, Florida. Dr. Sucandy is highly rated in 30 conditions, according to our data. His clinical expertise encompasses Cholangiocarcinoma (Bile Duct Cancer), Liver Cancer, Bile Duct Stricture, Hepatectomy, and Gallbladder Removal. Dr. Sucandy is currently accepting new patients.

Expertise in
16
conditions
Dr. Christine Laronga
General Surgery
Expertise in
16
conditions
Dr. Christine Laronga
General Surgery
Referral may be required

Moffitt Cancer Center, Richard M. Schulze Family Foundation Outpatient Center At McKinley Campus

10920 McKinley Dr, 
Tampa, FL 
 (1.1 miles away)
813-967-8245
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Christine Laronga is a General Surgeon practicing medicine in Tampa, Florida. Dr. Laronga is highly rated in 16 conditions, according to our data. Her clinical expertise encompasses Breast Cancer, HER2 Negative Breast Cancer, Triple-Negative Breast Cancer, Mastectomy, and Lymphadenectomy. Dr. Laronga is currently accepting new patients.

Frequently Asked Questions about Dr. Mokenge P. Malafa

How do I make an appointment with Dr. Mokenge P. Malafa?

You can book an appointment with Dr. Mokenge P. Malafa by calling their office at 813-773-4494. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Mokenge P. Malafa a top-rated expert for Pancreatic Cancer?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Mokenge P. Malafa is classified as an Elite expert for Pancreatic Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Mokenge P. Malafa specialize in?

While Dr. Mokenge P. Malafa is a General Surgery, they have specific expertise in Pancreatic Cancer, Pancreatectomy, and Familial Pancreatic Cancer. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within General Surgery.

Does Dr. Mokenge P. Malafa participate in research or clinical trials?

Yes. Dr. Mokenge P. Malafa has published 152 articles and abstracts on conditions like Pancreatic Cancer. You can view a list of Dr. Mokenge P. Malafa's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Mokenge P. Malafa accept my insurance?

Dr. Mokenge P. Malafa accepts most major insurance plans, including Aetna and Blue Cross Blue Shield. We recommend calling the office directly at 813-773-4494 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Malafa's expertise for a condition
ConditionClose
View All 8 Distinguished Conditions
View All 13 Advanced Conditions
View All 62 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile